{"id":"NCT01164501","sponsor":"Boehringer Ingelheim","briefTitle":"Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment","officialTitle":"A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group, Efficacy and Safety Study of BI 10773 (10 mg and 25 mg Administered Once Daily) as Add on to Pre-existing Antidiabetic Therapy Over 52 Weeks in Patients With Type 2 Diabetes Mellitus and Renal Impairment and Insufficient Glycaemic Control","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-07","primaryCompletion":"2012-07","completion":"2012-07","firstPosted":"2010-07-16","resultsPosted":"2014-06-16","lastUpdate":"2014-06-16"},"enrollment":741,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2","Renal Insufficiency"],"interventions":[{"type":"DRUG","name":"BI 10773","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"BI 10773","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"BI 10773 low dose","type":"EXPERIMENTAL"},{"label":"BI 10773 high dose","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will investigate the efficacy and safety of the BI 10773 in type 2 diabetic patients with renal impairment in order to provide these data for approval for BI 10773 as an antidiabetic agent by regulatory authorities.","primaryOutcome":{"measure":"HbA1c Change From Baseline in Patients With Mild or Moderate Renal Impairment","timeFrame":"Baseline and 24 weeks","effectByArm":[{"arm":"Placebo","deltaMin":0.05,"sd":0.04},{"arm":"Empa 25mg","deltaMin":-0.46,"sd":0.04}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":127,"countries":["United States","Canada","France","Hong Kong","India","Malaysia","Netherlands","Philippines","Poland","Portugal","Russia","Slovakia","South Africa","Spain","United Kingdom"]},"refs":{"pmids":["38770818","35472672","27316632","24795251"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":44,"n":319},"commonTop":["Hypoglycaemia","Urinary tract infection","Upper respiratory tract infection","Hyperglycaemia","Nasopharyngitis"]}}